Medical devices, healthcare technology and the business of care
FDA RECALL RECORD · Z-0527-2027

Ambra PACS (InteleShare) System, Image Processing, Radiological Recall

Ambra PACS (InteleShare) System, Image Processing, Radiological

FDA recall Class II

Open , Classified

FDA lists this Class II recall for Ambra PACS (InteleShare) System, Image Processing, Radiological. Review the affected identifiers, reported reason and manufacturer instructions below.

Recall at a glance

Recall number
Z-0527-2027
Recall classification
Class II
FDA database status
Open , Classified
Initiation date
Oct 21, 2026
FDA website posting date
Nov 20, 2026
Quantity in commerce
771 US; 60 OUS
Distribution
See key details
FDA cause
Not reported

What is being recalled?

Ambra PACS (InteleShare) System, Image Processing, Radiological

The retrieved code information does not contain explicit model/GTIN pairs that this publication can reliably map.

Search FDA identifier text

Search a model, catalog, lot or UDI value exactly as printed in FDA’s product description or code information.

This search checks only the FDA product description and code information displayed on this page. It does not decode a UDI, normalize GTIN lengths or establish a relationship between separately listed codes.

FDA code information

All InteleShare releases from 3.23.3.0 through 3.26.3.0. UDI-DI B228INTELESHARE0

View the original FDA recall notice

Why was this product recalled?

Two issues affect certain versions of the software: 1. Incomplete study duplication, and 2. Incomplete image archival. Either issue could result in a reader acting on an incomplete examination, which could result in misdiagnosis, delay in diagnosis or treatment, or require additional imaging.

These are potential consequences described in the source. The recall reason does not establish how many injuries or incidents occurred.

What actions did INTELERAD MEDICAL SYSTEMS INCORPORATED take?

Firm initially notified customers on October 21, 2026. However, this letter contained an error in the affected products section. The corrected version was sent to customers on October 28, 2026. This letter informs the customer of the issue and provides actions to be taken by the customer/user for continued use of the device. GE HealthCare will provide a software update to correct the issue.

Read the manufacturer action recorded by FDA

Recall timeline

  1. Recall initiated by firm

  2. FDA notice posted

Related FDA submissions

No submission number with an exact verified relationship is linked in the retrieved recall notice.

FDA’s notice explicitly links the submission numbers shown here. Read each filing for its own recorded device and scope.

Source and update history

The history starts with the versions held by MedtechLedger. Earlier source changes are not reconstructed. Official dates and recorded status come from FDA; page summaries describe the source information.

Our data sources and methodology